Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20034035HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20034036HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20022000HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20020582HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20020583HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20020736HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20033075HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20065160HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20065161HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20063306HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TCGA Plot Options
Drug Information
GeneCD274
DrugBank IDDB14776
Drug NameCamrelizumab
Target IDBE0003441
UniProt IDQ9NZQ7
Regulation Typeinhibitor
PubMed IDs33807678
CitationsKyriakidis I, Vasileiou E, Rossig C, Roilides E, Groll AH, Tragiannidis A: Invasive Fungal Diseases in Children with Hematological Malignancies Treated with Therapies That Target Cell Surface Antigens: Monoclonal Antibodies, Immune Checkpoint Inhibitors and CAR T-Cell Therapies. J Fungi (Basel). 2021 Mar 5;7(3). pii: jof7030186. doi: 10.3390/jof7030186.
GroupsInvestigational
Direct Classification
SMILES
Pathways
PharmGKB
ChEMBL